Actoplus and glycosylated haemoglobin increased Patient Reports February 12, 2012

Actoplus Side Effects Report #5692565-7
Actoplus side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2008. Male patient, 65 years of age, weighting 220.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Actoplus. After drug was administered, patient experienced the following side effects: arthralgia, blood glucose increased, glycosylated haemoglobin increased, meniscus lesion, precancerous skin lesion. Actoplus dosage: 15 MG/850 MG, 1 IN 1 D, PER ORAL; 15 MG/850 MG, 2 IN 1 D, PER ORAL. During the same period patient was treated with ACTOPLUS MET, ACTOS, TAZTIA XT, AVALIDE, METFORMIN. Patient recovered.

Actoplus Side Effects Report #4901302-2
Actoplus side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2006. Female patient, 26 years of age, weighting 329.0 lb, was treated with Actoplus. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, glycosylated haemoglobin increased. Actoplus dosage: 15/500 MG, 2 IN 1 D, PER ORAL. During the same period patient was treated with AVANDIA, NORTREL. Patient died on 01/29/2006.

Actoplus Side Effects Report #4907230-0
Actoplus side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2006. Female patient, 26 years of age, weighting 329.0 lb, was diagnosed with uterine haemorrhage and was treated with Actoplus. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, glycosylated haemoglobin increased, pulmonary embolism . Actoplus dosage: 15/500 MG, 2 IN 1 D, PER ORAL. During the same period patient was treated with NORTREL, AVANDIA. Patient died on 01/29/2006.